This series of brain scans is from a 36 year old male with over-focused, limbic, and inattentive ADD.
Originally this patient was stabilized on 150 mg. of Venlafaxine (Effexor) and 20 mg. of Amphetamine Sulfate (Adderall). He reduced his Venlafaxine (Effexor) for the test to 75 mg. and was on that amount throughout the entire 3 days of testing.
This first SPECT scan shows the typical depression in the prefrontal lobes during concentration with no medication except 75 mg. of Venlafaxine (Effexor).
During the second scan the patient took three capsules of the ADD-care® supplement and the lobe on the left closed completely and the lobe on the right hand side cleared by 85-90%.
The third scan was administered with 20 mg. of the most popular stimulant. The entire prefrontal cortex is almost completely smooth with the exception of a shallow depression in the lobe on the right side of the image. It was cleared by 95%. Overall, ADD-care performed about 85% as well as the stimulant on the surface scans.
This series of scans focuses on the internal parts of the brain. The lower part of the brain called the cerebellum should be all white showing good dopamine activity. As you can see his brain without any medication other than 75 mg. of the antidepressant had only a sliver of white at the extreme right. Any areas that show white outside of the cerebelum indicated a problem in that the brain is working 15% hotter than it should. Both the cingulate system and the basal ganglia are therefore overactive without meditation.
In the ADD-care® supplement scan the limbic system is decreased by more 70% and the basal ganglia have been reduced by 80-85%. The cingulate system is totally clear. The cerebellum is showing significantly more activity.
The third scan with 20 mg. of the most popular stimulant increased the cerebellum significantly, but the limbic system stayed inflamed. The cingulate system became grossly inflamed and the basal ganglia on the right increased significantly and the left basal ganglia became inflamed.
The ADD-care® supplement overall performed 25% as well as the stimulant with the cerebellum, and was 100% better with the cingulate system, 90% better with the basal ganglia, and 75% better with the limbic system. These impressive results were obtained despite the fact that the patient was having a raging anxiety attack due to the claustrophobia he was experiencing during the second scan. We were able to decrease the anxiety tremendously the night before the amphetamine scan by a series of psychological interventions that enabled him to be much less anxious on the thirdday. If the anxiety attacks were not occurring the results would have been even more spectacular.
During each scan the Connors ADD test was administered. During the first scan the patient missed 9 items and on the last two scans the patient missed no items so ADD-care® matched the popular stimulant on performance.